Page 30 - Cell Stem News Today

The researchers found, in line with the Covid-19 patient tissues, scarring of the kidney organoids and accompanying signals that contribute to the scarring process.

A team of international researchers have shown that SARS-CoV-2, the virus causing Covid-19, infects the kidneys and contributes to tissue scarring, possibly impacting kidney outcomes in the long term. �� COVID-19 Infects Kidneys and Leads to Tissue Scarring, Says Study.

The researchers found, in line with the Covid-19 patient tissues, scarring of the kidney organoids and accompanying signals that contribute to the scarring process.

A team of international researchers have shown that SARS-CoV-2, the virus causing Covid-19, infects the kidneys and contributes to tissue scarring, possibly impacting kidney outcomes in the long term.

The Coronavirus SARS-CoV-2 infects the kidneys and contributes to tissue scarring, as shown by researchers from the RWTH Uniklinik Aachen, Germany, and

New research findings shine a light on how the genes are activated. These findings have clinical implications for the inheritance of acquired traits, cancer, and other diseases.

Gene activation begins at the one-cell stage—far sooner than previously thought—which may change textbooks on developmental origins.

Incredible advances in growing living tissue in the lab took another amazing turn in August when a blob of brain cells grew eye-like structures

SAN DIEGO —A century ago, type 1 diabetes was a death sentence. But San Diego biotech ViaCyte says two studies published this week show the company is getting closer to

A first-of-its-kind study involving researchers at the University of British Columbia and Vancouver Coastal Health shows that a stem cell-based treatment delivered through an implantable device can produce insulin in Type 1 diabetes patients.